Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 243

1.

Yokukansan Ameliorates Hippocampus-Dependent Learning Impairment in Senescence-Accelerated Mouse.

Azuma K, Toyama T, Katano M, Kajimoto K, Hayashi S, Suzuki A, Tsugane H, Iinuma M, Kubo KY.

Biol Pharm Bull. 2018;41(10):1593-1599. doi: 10.1248/bpb.b18-00359.

2.

Catumaxomab with Activated T-cells Efficiently Lyses Chemoresistant EpCAM-positive Triple-negative Breast Cancer Cell Lines.

Kubo M, Umebayashi M, Kurata K, Mori H, Kai M, Onishi H, Katano M, Nakamura M, Morisaki T.

Anticancer Res. 2018 Jul;38(7):4273-4279. doi: 10.21873/anticanres.12724.

PMID:
29970561
3.

[Development of Holistic Cancer Treatment Centering Cancer Patients - From the Standpoint of Hypoxia and Hedgehog Signaling].

Onishi H, Ogino T, Morisaki T, Katano M.

Gan To Kagaku Ryoho. 2017 Nov;44(11):977-980. Japanese.

PMID:
29138370
4.

Phosphoproteome analysis of synoviocytes from patients with rheumatoid arthritis.

Katano M, Kurokawa MS, Matsuo K, Masuko K, Suematsu N, Okamoto K, Kamada T, Nakamura H, Kato T.

Int J Rheum Dis. 2017 Jun;20(6):708-721. doi: 10.1111/1756-185X.12997. Epub 2017 Mar 5.

PMID:
28261963
5.

Hedgehog signaling regulates PDL-1 expression in cancer cells to induce anti-tumor activity by activated lymphocytes.

Onishi H, Fujimura A, Oyama Y, Yamasaki A, Imaizumi A, Kawamoto M, Katano M, Umebayashi M, Morisaki T.

Cell Immunol. 2016 Dec;310:199-204. doi: 10.1016/j.cellimm.2016.08.003. Epub 2016 Aug 8.

PMID:
27522179
6.
7.

Production of Quaternary α-Aminonitriles by Means of Indium-Catalyzed Three-Component Reaction of Alkynes, Amines, and Trimethylsilyl Cyanide.

Hamachi Y, Katano M, Ogiwara Y, Sakai N.

Org Lett. 2016 Apr 1;18(7):1634-7. doi: 10.1021/acs.orglett.6b00508. Epub 2016 Mar 22.

PMID:
27001543
8.

Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.

Shinkai K, Nakano K, Cui L, Mizuuchi Y, Onishi H, Oda Y, Obika S, Tanaka M, Katano M.

Int J Cancer. 2016 Jul 15;139(2):433-45. doi: 10.1002/ijc.30075. Epub 2016 Mar 29.

9.

Suppressor Screen and Phenotype Analyses Revealed an Emerging Role of the Monofunctional Peroxisomal Enoyl-CoA Hydratase 2 in Compensated Cell Enlargement.

Katano M, Takahashi K, Hirano T, Kazama Y, Abe T, Tsukaya H, Ferjani A.

Front Plant Sci. 2016 Feb 17;7:132. doi: 10.3389/fpls.2016.00132. eCollection 2016.

10.

CD24 suppresses malignant phenotype by downregulation of SHH transcription through STAT1 inhibition in breast cancer cells.

Suyama K, Onishi H, Imaizumi A, Shinkai K, Umebayashi M, Kubo M, Mizuuchi Y, Oda Y, Tanaka M, Nakamura M, Katano M.

Cancer Lett. 2016 Apr 28;374(1):44-53. doi: 10.1016/j.canlet.2015.12.013. Epub 2016 Jan 12.

PMID:
26797459
11.

Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer.

Onishi H, Yamasaki A, Kawamoto M, Imaizumi A, Katano M.

Cancer Lett. 2016 Feb 28;371(2):143-50. doi: 10.1016/j.canlet.2015.11.012. Epub 2015 Nov 30.

PMID:
26655998
12.

New Approach to Complete Video-assisted Thoracoscopic Lobectomy in T2 and T3 Non-Small Cell Lung Cancer.

Kato M, Onishi H, Furugaki K, Yunotani S, Matsumoto K, Tsuruta N, Nakamura K, Katano M.

Anticancer Res. 2015 Jun;35(6):3585-9.

PMID:
26026131
13.

Forced expression of Nanog or Esrrb preserves the ESC status in the absence of nucleostemin expression.

Katano M, Ema M, Nakachi Y, Mizuno Y, Hirasaki M, Suzuki A, Ueda A, Nishimoto M, Takahashi S, Okazaki Y, Okuda A.

Stem Cells. 2015 Apr;33(4):1089-101. doi: 10.1002/stem.1918.

14.

Functional compensation between Myc and PI3K signaling supports self-renewal of embryonic stem cells.

Hishida T, Nakachi Y, Mizuno Y, Katano M, Okazaki Y, Ema M, Takahashi S, Hirasaki M, Suzuki A, Ueda A, Nishimoto M, Hishida-Nozaki Y, Vazquez-Ferrer E, Sancho-Martinez I, Izpisua Belmonte JC, Okuda A.

Stem Cells. 2015 Mar;33(3):713-25. doi: 10.1002/stem.1893.

15.

Surgical treatment to aid patients with colorectal perforation.

Onishi H, Sumiyoshi K, Terasaka R, Katano M.

In Vivo. 2014 Sep-Oct;28(5):997-1000.

PMID:
25189921
16.

NKG2D-directed cytokine-activated killer lymphocyte therapy combined with gemcitabine for patients with chemoresistant metastatic solid tumors.

Morisaki T, Hirano T, Koya N, Kiyota A, Tanaka H, Umebayashi M, Onishi H, Katano M.

Anticancer Res. 2014 Aug;34(8):4529-38. Erratum in: Anticancer Res. 2014 Sep;34(9):5227.

PMID:
25075096
17.

An epithelial cell adhesion molecule- and CD3-bispecific antibody plus activated T-cells can eradicate chemoresistant cancer stem-like pancreatic carcinoma cells in vitro.

Umebayashi M, Kiyota A, Koya N, Tanaka H, Onishi H, Katano M, Morisaki T.

Anticancer Res. 2014 Aug;34(8):4509-19.

PMID:
25075094
18.

Random migration contributes to cytotoxicity of activated CD8+ T-lymphocytes but not NK cells.

Onishi H, Kiyota A, Koya N, Tanaka H, Umebayashi M, Katano M, Morisaki T.

Anticancer Res. 2014 Aug;34(8):3947-56.

PMID:
25075016
19.

Prognostic significance of urine N1, N12-diacetylspermine in patients with non-small cell lung cancer.

Kato M, Onishi H, Matsumoto K, Motoshita J, Tsuruta N, Higuchi K, Katano M.

Anticancer Res. 2014 Jun;34(6):3053-9.

PMID:
24922672
20.

Different roles of two transcription factor B proteins in the hyperthermophilic archaeon Thermococcus kodakarensis.

Hidese R, Nishikawa R, Gao L, Katano M, Imai T, Kato S, Kanai T, Atomi H, Imanaka T, Fujiwara S.

Extremophiles. 2014 May;18(3):573-88. doi: 10.1007/s00792-014-0638-9. Epub 2014 Mar 14.

PMID:
24627188
21.

Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer.

Onishi H, Katano M.

World J Gastroenterol. 2014 Mar 7;20(9):2335-42. doi: 10.3748/wjg.v20.i9.2335. Review.

22.

Hedgehog signaling pathway is a potential therapeutic target for gallbladder cancer.

Matsushita S, Onishi H, Nakano K, Nagamatsu I, Imaizumi A, Hattori M, Oda Y, Tanaka M, Katano M.

Cancer Sci. 2014 Mar;105(3):272-80. doi: 10.1111/cas.12354. Epub 2014 Feb 18.

23.

NOTCH4 is a potential therapeutic target for triple-negative breast cancer.

Nagamatsu I, Onishi H, Matsushita S, Kubo M, Kai M, Imaizumi A, Nakano K, Hattori M, Oda Y, Tanaka M, Katano M.

Anticancer Res. 2014 Jan;34(1):69-80.

PMID:
24403446
24.

Reoxygenation from chronic hypoxia promotes metastatic processes in pancreatic cancer through the Hedgehog signaling.

Morifuji Y, Onishi H, Iwasaki H, Imaizumi A, Nakano K, Tanaka M, Katano M.

Cancer Sci. 2014 Mar;105(3):324-33. doi: 10.1111/cas.12348. Epub 2014 Feb 11.

25.

Striking similarity in the gene expression levels of individual Myc module members among ESCs, EpiSCs, and partial iPSCs.

Hirasaki M, Hiraki-Kamon K, Kamon M, Suzuki A, Katano M, Nishimoto M, Okuda A.

PLoS One. 2013 Dec 26;8(12):e83769. doi: 10.1371/journal.pone.0083769. eCollection 2013.

26.

Identification of Ccr4-not complex components as regulators of transition from partial to genuine induced pluripotent stem cells.

Kamon M, Katano M, Hiraki-Kamon K, Hishida T, Nakachi Y, Mizuno Y, Okazaki Y, Suzuki A, Hirasaki M, Ueda A, Nishimoto M, Kato H, Okuda A.

Stem Cells Dev. 2014 Sep 15;23(18):2170-9. doi: 10.1089/scd.2013.0326. Epub 2013 Dec 9.

27.

Tropomyosin-related kinase B inhibitor has potential for tumor regression and relapse prevention in pulmonary large cell neuroendocrine carcinoma.

Odate S, Onishi H, Nakamura K, Kojima M, Uchiyama A, Kato M, Katano M.

Anticancer Res. 2013 Sep;33(9):3699-703.

PMID:
24023298
28.

Abundant nucleostemin expression supports the undifferentiated properties of germ cell tumors.

Uema N, Ooshio T, Harada K, Naito M, Naka K, Hoshii T, Tadokoro Y, Ohta K, Ali MA, Katano M, Soga T, Nakanuma Y, Okuda A, Hirao A.

Am J Pathol. 2013 Aug;183(2):592-603. doi: 10.1016/j.ajpath.2013.04.018.

29.

In vivo function and evolution of the eutherian-specific pluripotency marker UTF1.

Nishimoto M, Katano M, Yamagishi T, Hishida T, Kamon M, Suzuki A, Hirasaki M, Nabeshima Y, Nabeshima Y, Katsura Y, Satta Y, Deakin JE, Graves JA, Kuroki Y, Ono R, Ishino F, Ema M, Takahashi S, Kato H, Okuda A.

PLoS One. 2013 Jul 9;8(7):e68119. doi: 10.1371/journal.pone.0068119. Print 2013.

30.

The Hedgehog inhibitor suppresses the function of monocyte-derived dendritic cells from patients with advanced cancer under hypoxia.

Onishi H, Morisaki T, Kiyota A, Koya N, Tanaka H, Umebayashi M, Katano M.

Biochem Biophys Res Commun. 2013 Jun 21;436(1):53-9. doi: 10.1016/j.bbrc.2013.05.057. Epub 2013 May 22.

PMID:
23707943
31.

A peculiar squamous dysplastic lesion presenting as a ground-glass opacity: a case report.

Atsumi J, Shimizu K, Nakano T, Kakegawa S, Sano T, Katano M, Hiroshima K, Takeyoshi I.

Eur Respir J. 2013 May;41(5):1228-30. doi: 10.1183/09031936.00098112. No abstract available.

32.

The Hedgehog inhibitor cyclopamine impairs the benefits of immunotherapy with activated T and NK lymphocytes derived from patients with advanced cancer.

Onishi H, Morisaki T, Kiyota A, Koya N, Tanaka H, Umebayashi M, Katano M.

Cancer Immunol Immunother. 2013 Jun;62(6):1029-39. doi: 10.1007/s00262-013-1419-5. Epub 2013 Apr 17.

PMID:
23591983
33.

Combining celecoxib with sorafenib synergistically inhibits hepatocellular carcinoma cells in vitro.

Morisaki T, Umebayashi M, Kiyota A, Koya N, Tanaka H, Onishi H, Katano M.

Anticancer Res. 2013 Apr;33(4):1387-95.

PMID:
23564777
34.

Protein-bound polysaccharide decreases invasiveness and proliferation in pancreatic cancer by inhibition of hedgehog signaling and HIF-1α pathways under hypoxia.

Onishi H, Morisaki T, Nakao F, Odate S, Morisaki T, Katano M.

Cancer Lett. 2013 Jul 28;335(2):289-98. doi: 10.1016/j.canlet.2013.02.041. Epub 2013 Feb 26.

PMID:
23485726
35.

TrkB/BDNF signaling pathway is a potential therapeutic target for pulmonary large cell neuroendocrine carcinoma.

Odate S, Nakamura K, Onishi H, Kojima M, Uchiyama A, Nakano K, Kato M, Tanaka M, Katano M.

Lung Cancer. 2013 Mar;79(3):205-14. doi: 10.1016/j.lungcan.2012.12.004. Epub 2013 Jan 9.

PMID:
23312550
36.

Intratumoral FOXP3+VEGFR2+ regulatory T cells are predictive markers for recurrence and survival in patients with colorectal cancer.

Suzuki H, Onishi H, Morisaki T, Tanaka M, Katano M.

Clin Immunol. 2013 Jan;146(1):26-33. doi: 10.1016/j.clim.2012.10.007. Epub 2012 Nov 5. Erratum in: Clin Immunol. 2013 Jul;148(1):148.

PMID:
23202541
37.

Hedgehog Gli3 activator signal augments tumorigenicity of colorectal cancer via upregulation of adherence-related genes.

Iwasaki H, Nakano K, Shinkai K, Kunisawa Y, Hirahashi M, Oda Y, Onishi H, Katano M.

Cancer Sci. 2013 Mar;104(3):328-36. doi: 10.1111/cas.12073. Epub 2013 Jan 10.

38.

Preoperative chemoradiotherapy using cisplatin plus S-1 can induce downstaging in patients with locally advanced (stage III) non-small-cell lung cancer.

Kato M, Onishi H, Matsumoto K, Tsuruta N, Higuchi K, Motoshita J, Katano M.

Anticancer Res. 2012 Nov;32(11):5099-104.

PMID:
23155287
39.

An archaeal histone is required for transformation of Thermococcus kodakarensis.

Čuboňováa L, Katano M, Kanai T, Atomi H, Reeve JN, Santangelo TJ.

J Bacteriol. 2012 Dec;194(24):6864-74. doi: 10.1128/JB.01523-12. Epub 2012 Oct 12.

40.

Short circuit in deep brain stimulation.

Samura K, Miyagi Y, Okamoto T, Hayami T, Kishimoto J, Katano M, Kamikaseda K.

J Neurosurg. 2012 Nov;117(5):955-61. doi: 10.3171/2012.8.JNS112073. Epub 2012 Sep 7.

PMID:
22957525
41.

Sirt1, p53, and p38(MAPK) are crucial regulators of detrimental phenotypes of embryonic stem cells with Max expression ablation.

Hishida T, Nozaki Y, Nakachi Y, Mizuno Y, Iseki H, Katano M, Kamon M, Hirasaki M, Nishimoto M, Okazaki Y, Okuda A.

Stem Cells. 2012 Aug;30(8):1634-44. doi: 10.1002/stem.1147.

42.

A new method for rapid cytotoxic T-lymphocyte induction using a multiple cytokine cocktail.

Onishi H, Koya N, Kiyota A, Tanaka H, Umebayashi M, Katano M, Morisaki T.

Anticancer Res. 2012 Jun;32(6):2385-90.

PMID:
22641679
43.

Short-term and low-dose prednisolone administration reduces aromatase inhibitor-induced arthralgia in patients with breast cancer.

Kubo M, Onishi H, Kuroki S, Okido M, Shimada K, Yokohata K, Umeda S, Ogawa T, Tanaka M, Katano M.

Anticancer Res. 2012 Jun;32(6):2331-6.

PMID:
22641670
44.

Combining cetuximab with killer lymphocytes synergistically inhibits human cholangiocarcinoma cells in vitro.

Morisaki T, Umebayashi M, Kiyota A, Koya N, Tanaka H, Onishi H, Katano M.

Anticancer Res. 2012 Jun;32(6):2249-56.

PMID:
22641659
45.

Cancer immunotherapy using NKG2D and DNAM-1 systems.

Morisaki T, Onishi H, Katano M.

Anticancer Res. 2012 Jun;32(6):2241-7. Review.

PMID:
22641658
46.

Hedgehog inhibitor decreases chemosensitivity to 5-fluorouracil and gemcitabine under hypoxic conditions in pancreatic cancer.

Onishi H, Morifuji Y, Kai M, Suyama K, Iwasaki H, Katano M.

Cancer Sci. 2012 Jul;103(7):1272-9. doi: 10.1111/j.1349-7006.2012.02297.x. Epub 2012 May 17.

47.

Immunotherapy approaches targeting regulatory T-cells.

Onishi H, Morisaki T, Katano M.

Anticancer Res. 2012 Mar;32(3):997-1003. Review.

PMID:
22399623
48.

The juvenile myoclonic epilepsy-related protein EFHC1 interacts with the redox-sensitive TRPM2 channel linked to cell death.

Katano M, Numata T, Aguan K, Hara Y, Kiyonaka S, Yamamoto S, Miki T, Sawamura S, Suzuki T, Yamakawa K, Mori Y.

Cell Calcium. 2012 Feb;51(2):179-85. doi: 10.1016/j.ceca.2011.12.011. Epub 2012 Jan 4.

PMID:
22226147
49.

Long-term vaccine therapy with autologous whole tumor cell-pulsed dendritic cells for a patient with recurrent rectal carcinoma.

Onishi H, Morisaki T, Baba E, Nakamura M, Inaba S, Kuroki H, Matsumoto K, Katano M.

Anticancer Res. 2011 Nov;31(11):3995-4005.

PMID:
22110233
50.

The E3 ubiquitin ligase activity of Trip12 is essential for mouse embryogenesis.

Kajiro M, Tsuchiya M, Kawabe Y, Furumai R, Iwasaki N, Hayashi Y, Katano M, Nakajima Y, Goto N, Watanabe T, Murayama A, Oishi H, Ema M, Takahashi S, Kishimoto H, Yanagisawa J.

PLoS One. 2011;6(10):e25871. doi: 10.1371/journal.pone.0025871. Epub 2011 Oct 18.

Supplemental Content

Loading ...
Support Center